UA95933C2 - ANTI-Ab GLOBULOMER ANTIBODIES, ANTIGEN-BINDING MOIETIES THEREOF, CORRESPONDING HYBRIDOMAS, NUCLEIC ACIDS, VECTORS, HOST CELLS, METHODS OF PRODUCING SAID ANTIBODIES, COMPOSITIONS COMPRISING SAID ANTIBODIES, USES OF SAID ANTIBODIES AND METHODS OF USING SAID ANTIBODIES - Google Patents
ANTI-Ab GLOBULOMER ANTIBODIES, ANTIGEN-BINDING MOIETIES THEREOF, CORRESPONDING HYBRIDOMAS, NUCLEIC ACIDS, VECTORS, HOST CELLS, METHODS OF PRODUCING SAID ANTIBODIES, COMPOSITIONS COMPRISING SAID ANTIBODIES, USES OF SAID ANTIBODIES AND METHODS OF USING SAID ANTIBODIESInfo
- Publication number
- UA95933C2 UA95933C2 UAA200808586A UAA200808586A UA95933C2 UA 95933 C2 UA95933 C2 UA 95933C2 UA A200808586 A UAA200808586 A UA A200808586A UA A200808586 A UAA200808586 A UA A200808586A UA 95933 C2 UA95933 C2 UA 95933C2
- Authority
- UA
- Ukraine
- Prior art keywords
- antibodies
- methods
- vectors
- nucleic acids
- producing
- Prior art date
Links
Landscapes
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Anti-Aglobulomer antibodies, antigen-binding moieties thereof, corresponding hybridomas, nucleic acids, vectors, host cells, methods of producing said antibodies, compositions comprising said antibodies, uses of said antibodies and methods of using said antibodies. The present invention relates to anti-Aglobulomer antibodies having a binding affinity to A(20-42) globulomer that is greater than the binding affinity of the antibody to A(1 -42) globulomer, antigen-binding moieties thereof, hybridomas producing said antibodies, nucleic acids encoding said antibodies, vectors comprising said nucleic acids, host cells comprising said vectors, methods of producing said antibodies, compositions comprising said antibodies, therapeutic and diagnostic uses of said antibodies and corresponding methods relating to Alzheimer's disease and other amyloidoses.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US74086605P | 2005-11-30 | 2005-11-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA95933C2 true UA95933C2 (en) | 2011-09-26 |
Family
ID=50779222
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA200808586A UA95933C2 (en) | 2005-11-30 | 2006-11-30 | ANTI-Ab GLOBULOMER ANTIBODIES, ANTIGEN-BINDING MOIETIES THEREOF, CORRESPONDING HYBRIDOMAS, NUCLEIC ACIDS, VECTORS, HOST CELLS, METHODS OF PRODUCING SAID ANTIBODIES, COMPOSITIONS COMPRISING SAID ANTIBODIES, USES OF SAID ANTIBODIES AND METHODS OF USING SAID ANTIBODIES |
Country Status (7)
| Country | Link |
|---|---|
| CN (2) | CN106008712A (en) |
| CA (1) | CA2918092C (en) |
| DK (1) | DK2289909T3 (en) |
| ME (1) | ME01826B (en) |
| NZ (1) | NZ629387A (en) |
| SI (3) | SI1954718T1 (en) |
| UA (1) | UA95933C2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3106116A1 (en) * | 2018-07-17 | 2020-01-23 | Jiangsu Hengrui Medicine Co., Ltd. | Anti-abeta antibody, antigen-binding fragment thereof and application thereof |
| CN109374902A (en) * | 2018-10-08 | 2019-02-22 | 杭州康知生物科技有限公司 | A kind of latex enhancing Immunoturbidimetric kit of quantitative detection IgG4 and preparation method thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7964192B1 (en) * | 1997-12-02 | 2011-06-21 | Janssen Alzheimer Immunotherapy | Prevention and treatment of amyloidgenic disease |
| CN1589903A (en) * | 1998-05-21 | 2005-03-09 | 田纳西州立大学研究基金会 | Methods for amyloid removal using anti-amyloid antibodies |
| UA81216C2 (en) * | 1999-06-01 | 2007-12-25 | Prevention and treatment of amyloid disease | |
| DE10303974A1 (en) * | 2003-01-31 | 2004-08-05 | Abbott Gmbh & Co. Kg | Amyloid β (1-42) oligomers, process for their preparation and their use |
-
2006
- 2006-11-30 NZ NZ629387A patent/NZ629387A/en unknown
- 2006-11-30 SI SI200631862T patent/SI1954718T1/en unknown
- 2006-11-30 SI SI200631887T patent/SI2289909T1/en unknown
- 2006-11-30 CN CN201510920823.0A patent/CN106008712A/en active Pending
- 2006-11-30 UA UAA200808586A patent/UA95933C2/en unknown
- 2006-11-30 DK DK10178394.2T patent/DK2289909T3/en active
- 2006-11-30 CN CN201510920357.6A patent/CN105924521A/en active Pending
- 2006-11-30 ME MEP-2014-38A patent/ME01826B/en unknown
- 2006-11-30 CA CA2918092A patent/CA2918092C/en active Active
- 2006-11-30 SI SI200631768T patent/SI1976877T1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2918092A1 (en) | 2007-06-07 |
| CA2918092C (en) | 2020-07-14 |
| CN105924521A (en) | 2016-09-07 |
| SI2289909T1 (en) | 2015-03-31 |
| DK2289909T3 (en) | 2015-02-02 |
| SI1976877T1 (en) | 2014-05-30 |
| NZ629387A (en) | 2016-01-29 |
| ME01826B (en) | 2014-12-20 |
| CN106008712A (en) | 2016-10-12 |
| SI1954718T1 (en) | 2015-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2007062852A3 (en) | ANTI-Aβ GLOBULOMER ANTIBODIES, ANTIGEN-BINDING MOIETIES THEREOF, CORRESPONDING HYBRIDOMAS, NUCLEIC ACIDS, VECTORS, HOST CELLS, METHODS OF PRODUCING SAID ANTIBODIES, COMPOSITIONS COMPRISING SAID ANTIBODIES, USES OF SAID ANTIBODIES AND METHODS OF USING SAID ANTIBODIES | |
| TW200732348A (en) | Monoclonal antibody | |
| WO2003017935A3 (en) | Human antibodies specific for interleukin 15 (il-15) | |
| HRP20040712B1 (en) | Anti-amyloid beta antibodies and their use | |
| UA97473C2 (en) | Normal;heading 1;heading 2;heading 3;ANTIBODIES DIRECTED TO HER-3 AND USES THEREOF | |
| MX2009013503A (en) | Monoclonal anti beta amyloid antibody. | |
| WO2008060364A3 (en) | Humani zed antibody against amyloid beta | |
| TW200500378A (en) | Human antibodies specific for interleukin 15 (IL-15) | |
| MX2009003468A (en) | Antibodies. | |
| AU2002257162A1 (en) | Humanized antibodies | |
| NO20062289L (en) | Antigen binding molecules with increased FC receptor binding affinity and effector function | |
| WO2007039818A3 (en) | Antigen binding molecules having modified fc regions and altered binding to fc receptors | |
| ZA200604026B (en) | IL-23 and its receptor ; related reagents and methods | |
| IL177337A0 (en) | Less immunogenic binding molecules | |
| WO2002095010A3 (en) | Human secreted proteins | |
| EP1308461A3 (en) | Antibodies to beta-amyloids or their derivatives and use thereof | |
| WO2011069992A3 (en) | Muteins of human lipocalin 2 (lcn2, hngal) with affinity for a given target | |
| WO2009028663A1 (en) | Anti-claudin-3 antibody | |
| UA102368C2 (en) | SPECIFIC IN RELATION b-AMYLOID 1-42 MONOKLONAL'NI ANTIBODIES WHICH ARE THERAPEUTIC CHARACTERISTICS | |
| WO2003004623A3 (en) | Human secreted proteins | |
| MXPA03010523A (en) | Antibodies specific for cd44v6. | |
| UA95933C2 (en) | ANTI-Ab GLOBULOMER ANTIBODIES, ANTIGEN-BINDING MOIETIES THEREOF, CORRESPONDING HYBRIDOMAS, NUCLEIC ACIDS, VECTORS, HOST CELLS, METHODS OF PRODUCING SAID ANTIBODIES, COMPOSITIONS COMPRISING SAID ANTIBODIES, USES OF SAID ANTIBODIES AND METHODS OF USING SAID ANTIBODIES | |
| ME01075B (en) | Antibodies | |
| DE60129736D1 (en) | NEW AGGRECANASE | |
| WO2004087759A3 (en) | Method and compositions for conversion of antibody activity |